Insys Therapeutics Q2 Profit Rises - Quick Facts

(RTTNews) - Insys Therapeutics Inc.(INSY) Tuesday reported a rise in its second-quarter earnings, helped by higher revenues, particularly from Subsys.

Net income improved to $9.5 million or $0.26 per share from $4.5 million or $0.17 per share last year. On an adjusted basis, the company earned $0.58 per share. On average, analysts polled by Thomson Reuters expected the company to report profit per share of $0.30 for the quarter. Analysts' estimates typically exclude special items.

Quarterly revenues rose to $55.7 million from $18.8 million in the second quarter of 2013, while analysts had consensus revenue estimate of $52.77 million.

Going forward, Insys said it is on track to submit a New Drug Application for Dronabinol Oral Solution during the third quarter and at least four Investigational New Drug applications with the Food and Drug Administration in the second half of 2014.